Dermatology
4 drugs are in development for Alopecia Areata.
- Companies
- 4
- Clinical trials
- 15
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Alopecia Areata pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(3)
Phase 1(1)
| Drug | Company |
|---|---|
| AQST-108 | Aquestive Therapeutics, Inc. (AQST) |
About this indication
Alopecia Areata context
Dermatology·MeSH: Alopecia Areata (D000506)
Also known as: Alopecia Circumscripta
Prevalence
200.0 / 100K
Incidence
20.0 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Alopecia Areata?
BioSniper tracks 4 drugs in development for Alopecia Areata across 4 companies.
How many clinical trials target Alopecia Areata?
There are 15 clinical trials targeting Alopecia Areata tracked by BioSniper.
What is the prevalence of Alopecia Areata?
The estimated prevalence of Alopecia Areata is approximately 200.0 per 100,000 population.